- Home
- ENVB
as 10-29-2025 9:38am EST
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | NAPLES |
| Market Cap: | 3.0M | IPO Year: | N/A |
| Target Price: | $10.00 | AVG Volume (30 days): | 61.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -84.90 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.63 - $99.00 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Enveric Biosciences Inc. News
ENVB Breaking Stock News: Dive into ENVB Ticker-Specific Updates for Smart Investing
Business Wire
6 days ago
Enveric Biosciences Announces Reverse Stock Split
Market Exclusive
10 days ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Business Wire
13 days ago
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
GuruFocus.com
14 days ago
AbbVie's Bretisilocin Hit With Enveric IP Claim
Investing.com
14 days ago
Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal
Business Wire
14 days ago
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
Business Wire
15 days ago
Enveric Biosciences to Explore Digital Asset Treasury Opportunities
Business Wire
a month ago
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials
Compare ENVB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENVB Enveric Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.